Pharmaceuticals (Dec 2023)

Tween 80-Based Self-Assembled Mixed Micelles Boost Valsartan Transdermal Delivery

  • Alaa Eldeen B. Yassin,
  • Salam Massadeh,
  • Abdullah A. Alshwaimi,
  • Raslan H. Kittaneh,
  • Mustafa E. Omer,
  • Dilshad Ahmad,
  • Al Hassan Aodah,
  • Faiyaz Shakeel,
  • Majed Halwani,
  • Saleh A. Alanazi,
  • Prawez Alam

DOI
https://doi.org/10.3390/ph17010019
Journal volume & issue
Vol. 17, no. 1
p. 19

Abstract

Read online

Valsartan (Val) is an important antihypertensive medication with poor absorption and low oral bioavailability. These constraints are due to its poor solubility and dissolution rate. The purpose of this study was to optimize a mixed micelle system for the transdermal delivery of Val in order to improve its therapeutic performance by providing prolonged uniform drug levels while minimizing drug side effects. Thin-film hydration and micro-phase separation were used to produce Val-loaded mixed micelle systems. A variety of factors, including the surfactant type and drug-to-surfactant ratio, were optimized to produce micelles with a low size and high Val entrapment efficiency (EE). The size, polydispersity index (PDI), zeta potential, and drug EE of the prepared micelles were all measured. The in vitro drug release profiles were assessed using dialysis bags, and the permeation through abdominal rat skin was assessed using a Franz diffusion cell. All formulations had high EE levels exceeding 90% and low particle charges. The micellar sizes ranged from 107.6 to 191.7 nm, with average PDI values of 0.3. The in vitro release demonstrated a uniform slow rate that lasted one week with varying extents. F7 demonstrated a significant (p 2/h through rat skin when compared to the control. As a result, the enhancement factor was 16.57. In summary, Val-loaded mixed micelles were successfully prepared using two simple methods with high reproducibility, and extensive transdermal delivery was demonstrated in the absence of any aggressive skin-modifying enhancers.

Keywords